BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 26253079)

  • 21. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.
    Warfel JM; Zimmerman LI; Merkel TJ
    Clin Vaccine Immunol; 2016 Jan; 23(1):47-54. PubMed ID: 26561389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis vaccines: state-of-the-art and future trends.
    Tefon BE; Özcengiz E; Özcengiz G
    Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of vaccination on the infectious diseases epidemiology: example of pertussis].
    Guiso N
    Med Sci (Paris); 2007 Apr; 23(4):399-403. PubMed ID: 17433230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live attenuated vaccines against pertussis.
    Locht C; Mielcarek N
    Expert Rev Vaccines; 2014 Sep; 13(9):1147-58. PubMed ID: 25085735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live pertussis vaccines: will they protect against carriage and spread of pertussis?
    Locht C
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S96-S102. PubMed ID: 28341014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pertussis vaccination for adolescents and adults.
    Franco E; Giambi C; Ialacci R; Maurici M
    Expert Opin Biol Ther; 2004 Oct; 4(10):1669-76. PubMed ID: 15461578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whither pertussis?
    Snelling TL; Waddington CS
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):145-8. PubMed ID: 25426699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.
    Esposito S; Stefanelli P; Fry NK; Fedele G; He Q; Paterson P; Tan T; Knuf M; Rodrigo C; Weil Olivier C; Flanagan KL; Hung I; Lutsar I; Edwards K; O'Ryan M; Principi N;
    Front Immunol; 2019; 10():1344. PubMed ID: 31333640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of pertussis: methods and implementation.
    Guiso N; Wirsing von König CH
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):657-67. PubMed ID: 27224518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.
    Sealey KL; Belcher T; Preston A
    Infect Genet Evol; 2016 Jun; 40():136-143. PubMed ID: 26932577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
    Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
    Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.
    Geurtsen J; Fae KC; van den Dobbelsteen GP
    Expert Rev Vaccines; 2014 Oct; 13(10):1229-40. PubMed ID: 25081731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis: pertussis control strategies and the options for improving current vaccines.
    Plotkin SA
    Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases.
    Damron FH; Barbier M; Dubey P; Edwards KM; Gu XX; Klein NP; Lu K; Mills KHG; Pasetti MF; Read RC; Rohani P; Sebo P; Harvill ET
    J Immunol; 2020 Aug; 205(4):877-882. PubMed ID: 32769142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.